Invenra
Madison, WI, United States invenra.com
From their website, Nov 2026
Work here? Claim this listing
About
Invenra develops and characterizes monoclonal, bispecific, and trispecific antibodies for drug discovery and development. It works with biotech and other research teams on discovery, expression, validation, and partnership programs, based in Madison, Wisconsin, United States.
Services
Monoclonal antibody discovery
Produces fully human mAb leads with binding properties, developability data, and functional validation.
Assays & in vitro testing
B-Body bispecific discovery
Screens bispecific combinations in final therapeutic format and delivers lead candidates ready for cell line development.
Assays & in vitro testing
B-Body bispecific expression
Expresses and purifies customer-provided sequences as B-Body bispecific antibodies.
Protein production
T-Body trispecific discovery
Develops trispecific antibody candidates for three-target engagement in a custom partnership model.
Assays & in vitro testing
Characterization and validation
Provides functional immunology, biophysical developability, and binding data for molecules at any stage.
Assays & in vitro testing
ADC program support
Supports antibody-drug conjugation-compatible platform work and ADC-related development.
- Turnaround
- ≤ 12 wks · 4 months from binder to lead candidates · 4-8 weeks from DNA to purified antibody
- What to send
- Antigen · Purified recombinant antigens · Cell lines · VH/VL sequences for each binding arm · Target biology and program goals
- Minimums and prices
- $100K starting price for mAb Discovery · $200K starting price for B-Body Discovery · $3,750 per molecule for B-Body Expression
Capabilities
- Assays and studies
- Antibodies · Bispecifics · ADCs · Immunogenicity · Mammalian expression · Cross-reactivity testing · Affinity (KD) measurements · Cell-based functional screening · Binding kinetics · Epitope diversity · Validated cell binding analysis · In silico liability scanning
8 more
Mass spectrometry intact mass confirmation · Developability assays · Formulation optimization · Thermal stability · Self-association · Aggregation · Solubility · Immunogenicity risk - Scale and capacity
- 30+ proprietary human phage libraries · 288+ bispecific combinations · 50 mL expression · 200 mL expression · 500 mL expression
- Therapeutic areas
- Cancer · Immuno-oncology
Instruments and platforms
- Carterra LSA
Modalities and species
- Modalities
- Antibody · Bispecific · ADC
- Species and models
- Human phage libraries · CHO cells
Company
- Type
- CRDMO
Locations
- Address
- 5510 Element Way Suite 400 Madison, WI 53719
- Sites
- Madison, United States
Similar labs
Work here? Claim this listing